I’m trying to calculate the projected revenues possible for this company if all goes well
The ED market is in the 2-3 billion dollar range with high CAGR. If the mango rx product can manage to take even a paltry 1 or 2% of that market then we are looking at multiple dollars per share as long as the SS is responsibly managed. With that said, that is an extremely unlikely scenario. But certainly not impossible based on my personal opinion.